富国沪港深创新药产业ETF(159748)利润分配表
| |
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
| 收入 |
-39,479,419.69 |
-83,890,442.13 |
-29,511,708.40 |
-34,453,768.42 |
| 利息合计 |
16,305.26 |
10,368.98 |
18,760.79 |
9,023.38 |
| 其中：存款利息收入 |
16,305.26 |
10,368.98 |
18,760.79 |
9,023.38 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-38,682,210.99 |
-25,062,711.13 |
-14,689,081.48 |
-4,203,026.99 |
| 其中：股票投资收益 |
-42,433,665.38 |
-27,384,767.99 |
-16,777,956.91 |
-5,493,691.65 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
3,751,454.39 |
2,322,056.86 |
2,088,875.43 |
1,290,664.66 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-1,295,547.77 |
-59,318,117.41 |
-15,382,898.30 |
-30,337,740.00 |
| 其他收入 |
482,033.81 |
480,017.43 |
541,510.59 |
77,975.19 |
| 费用 |
1,870,101.50 |
925,205.54 |
1,729,897.03 |
777,131.31 |
| 管理人报酬 |
1,272,966.25 |
628,595.90 |
1,161,235.60 |
508,700.86 |
| 基金托管费 |
254,593.19 |
125,719.15 |
232,247.01 |
101,740.10 |
| 销售服务费 |
- |
- |
- |
- |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
342,542.06 |
170,890.49 |
336,414.42 |
166,690.35 |
| 利润总额 |
-41,349,521.19 |
-84,815,647.67 |
-31,241,605.43 |
-35,230,899.73 |
微信公众号
证券之星APP
基本资料
